Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (9)

2022

  1. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

2018

  1. Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer

    European Respiratory Journal

  2. Pain assessment in mechanically ventilated, noncommunicative severe trauma patients

    Journal of Trauma Nursing, Vol. 25, Núm. 1, pp. 49-59

2017

  1. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

    Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11

  2. Variability of nutrients intake, lipid profile and cardiovascular mortality among geographical areas in Spain: The DRECE study

    Geospatial Health, Vol. 12, Núm. 2, pp. 245-251

2016

  1. Propensity score analysis of the role of initial antifungal therapy in the outcome of Candida glabrata bloodstream infections

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 6, pp. 3291-3300

2012

  1. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis

    Comprehensive Psychiatry, Vol. 53, Núm. 8, pp. 1063-1070

2007

  1. Immunogenicity and reactogenicity of primary immunization with a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine coadministered with a diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus vaccine at 2, 4 and 6 months

    Pediatric Infectious Disease Journal, Vol. 26, Núm. 1, pp. 1-7

2006

  1. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 8, pp. 713-720